The acting head of the Food and Drug Administration (FDA) urged for a government investigation into unusual contacts between members of her agency and the maker of a controversial new drug for Alzheimer’s disease Friday.
Dr. Janet Woodcock, acting commissioner of the FDA, tweeted that due to “ongoing interest and questions” she has asked the Office of the Inspector General, U.S. Department of Health and Human Services for an independent investigation into the “interactions between representatives of Biogen and FDA” during the approval process for Aduhelm, an Alzheimer’s drug.
The Daily Caller was founded in 2010 by Tucker Carlson, a 20-year veteran journalist, and Neil Patel, former chief policy advisor to Vice President Cheney, The Daily Caller is one of America’s largest and fastest-growing news publications. Our team of experienced, full-time reporters and editors works around the clock to deliver award-winning original reporting, in-depth investigations, entertainment, thought-provoking commentary and up-to-the-second breaking news. Visit https://dailycaller.com